IP Library Granted Patent US 8,470,595
Granted Patent B2
US 8,470,595 · App. 12/988,381 · Granted Jun 25, 2013

Mesenchymal stem cell and method for production thereof

Inventors: Shigeko Torihashi (Nagoya, JP); Nana Ninagawa (Nagoya, JP)
Assignee: National University Corporation Nagoya University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,595
App. No.
12/988,381
Granted
Jun 25, 2013
Kind
B2
Abstract

The present invention provides a method for producing a mesenchymal stem cell having an ability to differentiate into a myoblast by culturing a pluripotent stem cell derived from a human or animal, including: i) preparing the pluripotent stem cell that has been cryopreserved, ii) sub-culturing the prepared pluripotent stem cell in an undifferentiated state for a prescribed number of times, iii) culturing the subcultured pluripotent stem cell under conditions that enable induction of differentiation into an adipocyte in vitro, and iv) separating and collecting a CD105-positive cell during the culturing process.

Claims (9)

1. A method for producing a myoblast by culturing mouse-derived pluripotent stem cells, the method comprising:

i) preparing the mouse-derived pluripotent stem cells that have been cryopreserved;

ii) sub-culturing the prepared mouse-derived pluripotent stem cells 8 to 12 times in an undifferentiated state, wherein the mouse-derived pluripotent stem cells are sub-cultured in a medium containing leukemia inhibitory factor (LIF);

iii) culturing the subcultured mouse-derived pluripotent stem cell under conditions that enable induction of differentiation into an adipocyte in vitro, wherein the conditions include suspension-culturing in a medium containing retinoic acid for 2 to 3 days, followed by culturing in a medium containing insulin and triiodothyronine (T3), and wherein the time period of the iii) culturing is 7 to 21 days from the start of the culturing following the ii) sub-culturing;

iv) separating and collecting a CD105-positive mesenchymal stem cell after the culturing in the medium containing insulin and T3; and

v) further culturing the separated and collected CD105-positive cell under conditions that enable induction of differentiation into a myoblast in vitro, wherein the collected CD105-positive cells are cultured in ES cell culture medium containing serum or serum replacement.

2. The method according to claim 1 , wherein the iii) culturing the subcultured mouse-derived pluripotent stem cell under conditions that enable induction of differentiation into an adipocyte is carried out for 7 to 14 days.

3. The method according to claim 1 , wherein the ii) sub-culturing the prepared mouse-derived pluripotent stem cell is carried out 9 to 11 times.

4. The method according to claim 1 , wherein the mouse-derived pluripotent stem cells are mouse ES cells are mouse iPS cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2010
From: TORIHASHI, SHIGEKO; NINAGAWA, NANA
To: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY
Reel/Frame 025541/0734 →
Priority Claims (1)
JP 2008-109002 · Apr 18, 2008 · national
Continuity (1)
Related Publication 20110111499A1 · May 12, 2011